These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 33236953)

  • 1. Sarcopenia in chronic liver disease: mechanisms and countermeasures.
    Allen SL; Quinlan JI; Dhaliwal A; Armstrong MJ; Elsharkawy AM; Greig CA; Lord JM; Lavery GG; Breen L
    Am J Physiol Gastrointest Liver Physiol; 2021 Mar; 320(3):G241-G257. PubMed ID: 33236953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcopenia in Chronic Liver Disease: A Metabolic Perspective.
    Kumar R; Prakash SS; Priyadarshi RN; Anand U
    J Clin Transl Hepatol; 2022 Dec; 10(6):1213-1222. PubMed ID: 36381104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cause and management of muscle wasting in chronic liver disease.
    Dasarathy S
    Curr Opin Gastroenterol; 2016 May; 32(3):159-65. PubMed ID: 26974417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcopenia in cirrhosis: from pathogenesis to interventions.
    Ebadi M; Bhanji RA; Mazurak VC; Montano-Loza AJ
    J Gastroenterol; 2019 Oct; 54(10):845-859. PubMed ID: 31392488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research advances of sarcopenia in chronic liver disease].
    Xiao HJ; Zhang M; Qi YM; Han T
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):563-566. PubMed ID: 31357787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcopenia in Alcoholic Liver Disease: Clinical and Molecular Advances.
    Dasarathy J; McCullough AJ; Dasarathy S
    Alcohol Clin Exp Res; 2017 Aug; 41(8):1419-1431. PubMed ID: 28557005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcopenia and chronic liver diseases.
    Hsu CS; Kao JH
    Expert Rev Gastroenterol Hepatol; 2018 Dec; 12(12):1229-1244. PubMed ID: 30791794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcopenia from mechanism to diagnosis and treatment in liver disease.
    Dasarathy S; Merli M
    J Hepatol; 2016 Dec; 65(6):1232-1244. PubMed ID: 27515775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective Effect of Angiotensin 1-7 on Sarcopenia Induced by Chronic Liver Disease in Mice.
    Aguirre F; Abrigo J; Gonzalez F; Gonzalez A; Simon F; Cabello-Verrugio C
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32485991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Mechanisms and Treatment of Sarcopenia in Liver Disease: A Review of Current Knowledge.
    Kamimura H; Sato T; Natsui K; Kobayashi T; Yoshida T; Kamimura K; Tsuchiya A; Murayama T; Yokoyama J; Kawai H; Takamura M; Terai S
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcopenia: Ammonia metabolism and hepatic encephalopathy.
    Jindal A; Jagdish RK
    Clin Mol Hepatol; 2019 Sep; 25(3):270-279. PubMed ID: 31006226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of lithocholic acid with skeletal muscle hypertrophy through TGR5-IGF-1 and skeletal muscle mass in cultured mouse myotubes, chronic liver disease rats and humans.
    Tamai Y; Eguchi A; Shigefuku R; Kitamura H; Tempaku M; Sugimoto R; Kobayashi Y; Iwasa M; Takei Y; Nakagawa H
    Elife; 2022 Oct; 11():. PubMed ID: 36206032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Mechanism Contributing to Malnutrition and Sarcopenia in Patients with Liver Cirrhosis.
    Meyer F; Bannert K; Wiese M; Esau S; Sautter LF; Ehlers L; Aghdassi AA; Metges CC; Garbe LA; Jaster R; Lerch MM; Lamprecht G; Valentini L
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32731496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sarcopenia in Chronic Liver Disease].
    Seo KI
    Korean J Gastroenterol; 2023 Nov; 82(5):233-238. PubMed ID: 37997219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperammonemia and proteostasis in cirrhosis.
    Dasarathy S; Hatzoglou M
    Curr Opin Clin Nutr Metab Care; 2018 Jan; 21(1):30-36. PubMed ID: 29035972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation and Management of Nutritional Consequences of Chronic Liver Diseases.
    Espina S; Casas-Deza D; Bernal-Monterde V; Domper-Arnal MJ; García-Mateo S; Lué A
    Nutrients; 2023 Aug; 15(15):. PubMed ID: 37571424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcopenia in end-stage liver disease and after liver transplantation.
    Leunis S; Vandecruys M; Van Craenenbroeck AH; Cornelissen V; Bogaerts S; De Smet S; Monbaliu D
    Acta Gastroenterol Belg; 2023; 86(2):323-334. PubMed ID: 37428166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis.
    Kumar A; Davuluri G; Silva RNE; Engelen MPKJ; Ten Have GAM; Prayson R; Deutz NEP; Dasarathy S
    Hepatology; 2017 Jun; 65(6):2045-2058. PubMed ID: 28195332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The age-related loss of skeletal muscle mass and function: Measurement and physiology of muscle fibre atrophy and muscle fibre loss in humans.
    Wilkinson DJ; Piasecki M; Atherton PJ
    Ageing Res Rev; 2018 Nov; 47():123-132. PubMed ID: 30048806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging Treatment Options for Sarcopenia in Chronic Liver Disease.
    Kim Y
    Life (Basel); 2021 Mar; 11(3):. PubMed ID: 33803020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.